When drug companies select what they want to publish patients are denied relevant therapeutic information.
Filippini
Graziella
G
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Moja
Lorenzo
L
Liberati
Alessandro
A
Gensini
Gian Franco
GF
Gusinu
Roberto
R
Conti
Andrea A
AA
D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011643:Publishing
D016898:Interferon-alpha; D016899:Interferon-beta